Clara Biotech is a platform technology that allow for the isolation of specific cellular markers (exosomes) from very small fluid samples enabling liquid biopsy for the very early detection of cancer, Alzheimer’s Disease and many others. These same markers can also be turned into a precision medicine drug delivery platform delivering targeted drugs directly to the cells being targeted. The current gold standard is a 12 hours ultra-centrifugation process. Ours is the only platform that can take any biofluid source, and extract any species of pure viable exosome into pure solution. We are the bridge that moves research to patient. Exosomes are one of the next major breakthroughs in Biotech. We are Clara. We are exosomes.
